Core Laboratories Inc. (NYSE:CLB) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. lowered its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 65.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,796 shares of the oil and gas company's stock after selling 221,067 shares during the period. Ameriprise Financial Inc. owned about 0.25% of Core Laboratories worth $2,022,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Franklin Resources Inc. acquired a new position in shares of Core Laboratories in the 4th quarter worth approximately $464,000. Amundi lifted its holdings in shares of Core Laboratories by 194.8% in the 4th quarter. Amundi now owns 32,968 shares of the oil and gas company's stock worth $600,000 after acquiring an additional 21,783 shares during the last quarter. Boston Trust Walden Corp lifted its holdings in shares of Core Laboratories by 2.7% in the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company's stock worth $10,686,000 after acquiring an additional 16,503 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of Core Laboratories by 15.6% in the 4th quarter. Northern Trust Corp now owns 577,752 shares of the oil and gas company's stock worth $10,001,000 after acquiring an additional 78,173 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of Core Laboratories by 3.1% in the 4th quarter. Principal Financial Group Inc. now owns 229,096 shares of the oil and gas company's stock worth $3,966,000 after acquiring an additional 6,827 shares during the last quarter. Hedge funds and other institutional investors own 97.81% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CLB. Stifel Nicolaus reduced their target price on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a report on Tuesday, April 15th. Citigroup dropped their price objective on shares of Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 13th. Finally, Wall Street Zen downgraded shares of Core Laboratories from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $15.00.

Core Laboratories Price Performance

Shares of NYSE CLB traded down $0.25 during midday trading on Friday, hitting $10.78. The company had a trading volume of 580,220 shares, compared to its average volume of 405,556. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49. Core Laboratories Inc. has a twelve month low of $10.14 and a twelve month high of $25.13. The business has a 50-day simple moving average of $12.18 and a two-hundred day simple moving average of $15.85. The firm has a market capitalization of $505.40 million, a price-to-earnings ratio of 16.33, a price-to-earnings-growth ratio of 0.99 and a beta of 1.45.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. The business had revenue of $123.59 million for the quarter, compared to analyst estimates of $125.09 million. During the same quarter in the previous year, the firm posted $0.19 EPS. The business's revenue was down 4.7% on a year-over-year basis. Equities research analysts anticipate that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, May 5th. This represents a $0.04 annualized dividend and a yield of 0.37%. Core Laboratories's dividend payout ratio is currently 6.78%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.